214 related articles for article (PubMed ID: 29191489)
1. Beyond the vicious cycle: The role of innate osteoimmunity, automimicry and tumor-inherent changes in dictating bone metastasis.
Owen KL; Parker BS
Mol Immunol; 2019 Jun; 110():57-68. PubMed ID: 29191489
[TBL] [Abstract][Full Text] [Related]
2. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.
Chung LW; Baseman A; Assikis V; Zhau HE
J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic immune infiltrates are essential for the efficient formation of breast cancer liver metastases.
Tabariès S; Ouellet V; Hsu BE; Annis MG; Rose AA; Meunier L; Carmona E; Tam CE; Mes-Masson AM; Siegel PM
Breast Cancer Res; 2015 Mar; 17(1):45. PubMed ID: 25882816
[TBL] [Abstract][Full Text] [Related]
4. Targeting Intercellular Communication in the Bone Microenvironment to Prevent Disseminated Tumor Cell Escape from Dormancy and Bone Metastatic Tumor Growth.
Kreps LM; Addison CL
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33805598
[TBL] [Abstract][Full Text] [Related]
5. Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer.
Futakuchi M; Fukamachi K; Suzui M
Adv Drug Deliv Rev; 2016 Apr; 99(Pt B):206-211. PubMed ID: 26656603
[TBL] [Abstract][Full Text] [Related]
6. Bone metastasis and the metastatic niche.
Ren G; Esposito M; Kang Y
J Mol Med (Berl); 2015 Nov; 93(11):1203-12. PubMed ID: 26275789
[TBL] [Abstract][Full Text] [Related]
7. Novel Techniques to Study the Bone-Tumor Microenvironment.
Shupp AB; Kolb AD; Bussard KM
Adv Exp Med Biol; 2020; 1225():1-18. PubMed ID: 32030644
[TBL] [Abstract][Full Text] [Related]
8. Bone metastasis in prostate cancer: Recurring mitochondrial DNA mutation reveals selective pressure exerted by the bone microenvironment.
Arnold RS; Fedewa SA; Goodman M; Osunkoya AO; Kissick HT; Morrissey C; True LD; Petros JA
Bone; 2015 Sep; 78():81-6. PubMed ID: 25952970
[TBL] [Abstract][Full Text] [Related]
9. Targeting tumor-stromal interactions in bone metastasis.
Esposito M; Kang Y
Pharmacol Ther; 2014 Feb; 141(2):222-33. PubMed ID: 24140083
[TBL] [Abstract][Full Text] [Related]
10. The Impact of Immune System in Regulating Bone Metastasis Formation by Osteotropic Tumors.
D'Amico L; Roato I
J Immunol Res; 2015; 2015():143526. PubMed ID: 26064994
[TBL] [Abstract][Full Text] [Related]
11. Tasquinimod inhibits prostate cancer growth in bone through alterations in the bone microenvironment.
Magnusson LU; Hagberg Thulin M; Plas P; Olsson A; Damber JE; Welén K
Prostate; 2016 Mar; 76(4):383-93. PubMed ID: 26660725
[TBL] [Abstract][Full Text] [Related]
12. Examining the metastatic niche: targeting the microenvironment.
Guise T
Semin Oncol; 2010 Oct; 37 Suppl 2():S2-14. PubMed ID: 21111245
[TBL] [Abstract][Full Text] [Related]
13. Amino Acid Metabolism in Bone Metastatic Disease.
Edwards DN
Curr Osteoporos Rep; 2023 Aug; 21(4):344-353. PubMed ID: 37277592
[TBL] [Abstract][Full Text] [Related]
14. Crosstalk between bone niche and immune system: osteoimmunology signaling as a potential target for cancer treatment.
Criscitiello C; Viale G; Gelao L; Esposito A; De Laurentiis M; De Placido S; Santangelo M; Goldhirsch A; Curigliano G
Cancer Treat Rev; 2015 Feb; 41(2):61-8. PubMed ID: 25499997
[TBL] [Abstract][Full Text] [Related]
15. The Contribution of the Immune System in Bone Metastasis Pathogenesis.
Xiang L; Gilkes DM
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602
[TBL] [Abstract][Full Text] [Related]
16. Integrating new discoveries into the "vicious cycle" paradigm of prostate to bone metastases.
Cook LM; Shay G; Araujo A; Lynch CC
Cancer Metastasis Rev; 2014 Sep; 33(2-3):511-25. PubMed ID: 24414228
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of the Stromal p38MAPK/MK2 Pathway Limits Breast Cancer Metastases and Chemotherapy-Induced Bone Loss.
Murali B; Ren Q; Luo X; Faget DV; Wang C; Johnson RM; Gruosso T; Flanagan KC; Fu Y; Leahy K; Alspach E; Su X; Ross MH; Burnette B; Weilbaecher KN; Park M; Mbalaviele G; Monahan JB; Stewart SA
Cancer Res; 2018 Oct; 78(19):5618-5630. PubMed ID: 30093561
[TBL] [Abstract][Full Text] [Related]
18. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
19. Emerging roles for myeloid immune cells in bone metastasis.
Alsamraae M; Cook LM
Cancer Metastasis Rev; 2021 Jun; 40(2):413-425. PubMed ID: 33855680
[TBL] [Abstract][Full Text] [Related]
20. Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis.
Luo G; He Y; Zhao Q; Yu X
Recent Pat Anticancer Drug Discov; 2017; 12(3):221-233. PubMed ID: 28595538
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
